眼部护理

Improving standards for all
\r\nBridging our understanding of biological processes and the genetic basis of human disease to accelerate ophthalmic drug discovery.
\r\n
\r\nFinding new approaches
\r\nLeading innovation in long-acting therapeutic approaches via mechanism of action, sustained-release formulations or gene therapy to reduce the treatment burden.
\r\n
\r\nCollaboration in innovation
\r\nWorking with colleagues across AbbVie to seize the scientific opportunity of innovation within oncology, immunology and neuroscience through knowledge of common disease pathways.
\r\n
\r\nState-of-the-art imagery
\r\nApplying state-of-the-art imaging modalities to monitor disease progression and therapeutic intervention to accelerate the translation of bench science to the clinic.
\r\n
\r\nStrategic collaboration
\r\nJoining forces with innovative partners that complement our strengths, capabilities and commitments to eye care, including our work in chronic retinal diseases with REGENXBIO.

每年有更多的人将获得该诊断由于老化和生活方式因素。我们强大的研究和开发方法是固定在改善跨多个疾病护狗万正网地址理领域的标准对病人做出有意义的差别。

我们的研究,关注未满足的需求,燃料创新型管道的治疗寻求保护,保护视力,防止失明。我们的研究兴趣包括:

提高标准,适用于所有
桥接我们理解生物过程和人类疾病的遗传基础,加快眼科药物发现。

寻找新方法
领先创新长效治疗方法通过作用机理、缓释配方或基因疗法来减少治疗的负担。

合作创新
与同事工作在AbbVie抓住科学创新的机会在肿瘤学,免疫学和神经科学知识常见疾病的途径。

先进的图像
应用先进的成像技术来监测疾病进展和治疗干预,加快长椅上科学的翻译到诊所。

战略协作
联合创新的伙伴,补充我们的优势,眼部护理能力和承诺,包括我们的工作与REGENXBIO慢性视网膜疾病。